A CME/ABIM MOC/ABD MOC Activity

TO REGISTER:
Click here to complete your registration.


If you will be watching the webinar in a group setting, please note all group participants will need to register individually in order to complete the post-test and evaluation to receive credit.

DATES AND TIMES

AGENDA
Welcome and Introduction
Diagnosing and Assessing Severity of Pustular Psoriasis
Managing Pustular Psoriasis
Q&A Session and Activity Roundup

PROGRAM DESCRIPTION
Pustular psoriasis is a group of rare psoriasis subtypes typified by aseptic, neutrophil-rich pustules. The three most common types are generalized pustular psoriasis, palmoplantar pustular psoriasis, and acrodermatitis continua of Hallopeau. The diagnosis of pustular psoriasis relies primarily on clinical features and may be difficult. Recent guidelines on diagnosis, classification, and assessment of severity have been published by ERASPEN and by the Japanese Dermatological Association.

Treatment of pustular psoriasis involves systemic therapy with cyclosporine, methotrexate or acitretin. Guidelines and a treatment algorithm have been published by the Japanese Dermatological Association. The understanding that IL-36 cytokines are likely the key driver of the autoimmune response in pustular psoriasis has led to the development of two novel, investigational monoclonal antibodies that target the IL-36 receptor. In addition, agents that target other molecules have also been investigated.

Diagnosing and Managing Pustular Psoriasis: A Rare But Serious Disease will provide clinicians with information about the most recent guidelines for diagnosing, classifying, and assessing the severity of pustular psoriasis. Current treatment guidelines and a review of agents in development will help clinicians manage this rare group of disorders.

STEERING COMMITTEE
M. Susan Burke, MD, FACP
Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Philadelphia, PA
Senior Advisor, Lankenau Medical Associates
                       Lankenau Medical Center
                       Wynnewood, PA

Ahuva Cices, MD
Dermatology Resident
Icahn School of Medicine at Mount Sinai
New York, NY

Mark Lebwohl, MD
Dean for Clinical Therapeutics
Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY

TARGET AUDIENCE
The intended audience for this educational initiative is primary care physicians and other clinicians who may diagnose and manage patients with pustular psoriasis.

EDUCATIONAL OBJECTIVES
At the conclusion of an activity, participants should be able to:

• Describe the pathophysiology of pustular psoriasis and how it is different from that of plaque psoriasis
• Use current guidelines to diagnose and classify pustular psoriasis
• Employ current guidelines when managing patients with pustular psoriasis
• Assess the mechanism of action, efficacy, and safety of agents in development for managing pustular psoriasis

PHYSICIAN ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION STATEMENT
The Potomac Center for Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For questions regarding CME credit or the evaluation, please email contact@potomacme.org.

ABIM MOC RECOGNITION STATEMENT
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through PCME’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

AMERICAN BOARD OF DERMATOLOGY MOC INFORMATION
Dermatologists certified by the American Board of Dermatology (ABD) must earn a minimum of 25 hours of AMA PRA Category 1 Credits™ annually. Half of these credits must be Dermatology practice-specific CME credits from accredited organizations in order to fulfill the lifelong learning component of MOC. Participation in this activity will support board certified dermatologists in contributing towards this MOC requirement set forth by the ABD.

DISCLOSURE INFORMATION
The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

Disclosures will be made known to the participants prior to the start of the activity.

FDA DISCLOSURE
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

SYSTEM CHECK
To ensure your computer is compatible for the live event, please perform a system check by clicking on the link http://livewebcast.net/test or by typing it into your internet browser. Please perform the system check on the same computer you will use for the live event. If your computer is compatible, you will receive a confirmation message on your screen and hear audio. Otherwise, please contact the Help Desk to resolve any issues.

HARDWARE REQUIREMENTS
WINDOWS

• 1.4 GHz Intel Pentium 4 or faster processor (or equivalent)
• Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit)
• 512 MB of RAM (1 GB recommended)
• Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome
• For HTML Client - Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above)

MAC OS

• 1.83 GHz Intel Core Duo or faster processor
• 512 MB RAM (1 GB recommended)
• Mac OS X 10.12, 10.13 and 10.14
• Mozilla Firefox, Apple Safari, Google Chrome
• For HTML Client - Google Chrome (v70.0 & above), Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above)

MOBILE

• The Adobe Connect app for iOS and Android requires Adobe Connect Server version 8.2 or later
• Some features may not be enabled in all Adobe Connect meetings if one is using an Adobe Connect Server older than version 9.4.2 (required for Custom pods)
• Google Android 4.4 or later
• Apple iOS: iOS 8.1.2 or later

SOFTWARE REQUIREMENTS
DSL/cable (wired connection recommended)

INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME CREDIT/MOC POINTS
There is no fee for this activity. To receive credit, participants must register, view the live CME/MOC activity in its entirety, and then complete the post-test with a score of 80% or better and the evaluation. The estimated time for completion of this activity is 1 hour. To receive a certificate, participants must demonstrate mastery of the presented material via the post-test. Participants are allowed to take the post-test multiple times.

Jointly provided by the Potomac Center for Medical Education and Rockpointe
  

In collaboration with 


This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

PCME Privacy Policy